Development and clinical validation of a microfluidic-based platform for CTC enrichment and downstream molecular analysis.

Frontiers in oncology(2023)

引用 0|浏览12
暂无评分
摘要
The microfluidic-based CTC enrichment platform and downstream molecular analysis together provide a possible alternative to tissue biopsy for precision cancer management, especially for patients whose tissue biopsies are unavailable.
更多
查看译文
关键词
microfluidic chip, circulating tumor cells, CTC separation platforms, downstream molecular analysis, CTC counts
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要